BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study (Q34561970)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study |
scientific article |
Statements
1 reference
BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study (English)
1 reference
A G G Turpie
1 reference
W D Fisher
1 reference
K A Bauer
1 reference
L M Kwong
1 reference
M W Irwin
1 reference
P Kälebo
1 reference
F Misselwitz
1 reference
M Gent
1 reference
OdiXa-Knee Study Group
1 reference
1 November 2005
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference